Role of interleukin-8 in the progression of estrogen receptor-negative breast cancer - PubMed (original) (raw)

. 2007 Oct 20;120(20):1766-72.

Affiliations

• PMID: 18028768

Role of interleukin-8 in the progression of estrogen receptor-negative breast cancer

Chen Yao et al. Chin Med J (Engl). 2007.

Abstract

Background: Estrogen receptor (ER) is a very important biomarker of breast cancer. ER deletion has been consistently associated with tumor progression, recurrence, metastasis and poor prognosis, but the biological mechanism is still unclear. ER negative breast cancer expresses high levels of interleukin-8 (IL-8). ER expression can downregulate IL-8 promotor activity. As a multifunctional cytokine, IL-8 has many important biological activities in tumor genesis and development. With the goal of investigating the role of IL-8 in ER-negative breast cancer progression, we applied RNA interference technology to specifically knockdown the IL-8 expression in ER-negative breast cancer cell line MDA-MB-231.

Methods: Interfering pRNA-IL-8 and the control was transfected into ER (-) MDA-MB-231. The proliferation, cell apotosis, and invasive ability were recorded in transfected, untransfected and negative transfected cells. These cells were injected into nude mice to assess tumorigenicity, proliferation, metastasis and microvessel density (MVD).

Results: In vitro, decreased expression of IL-8 was associated with reduced cell invasion (P < 0.001), but had no effect on cell proliferation (P > 0.05). In vivo, neutrophils infiltration was significantly inhibited in pRNA-IL-8 transfected cells compared with untransfected and negatively transfected cells (P = 0.001, P < 0.001). Less metastasis was found in transfected cells compared with negatively transfected cells (0% vs 80%, P = 0.048). Nevertheless, we observed less MVD in transfected cells compared with control in nude mice (P < 0.001).

Conclusions: IL-8 inhibits ER-negative breast cancer cell growth and promotes its metastasis in vivo, which may be correlated with neutrophils infiltration induced by IL-8.

PubMed Disclaimer

Similar articles

• [Angiogenic effect of interleukin-8 in breast cancer and its association with estrogen receptor].
  Lin Y, Wang SM, Huang RP. Lin Y, et al. Zhonghua Yi Xue Za Zhi. 2005 Jun 1;85(20):1419-23. Zhonghua Yi Xue Za Zhi. 2005. PMID: 16029657 Chinese.
• [Estrogens, cathepsin D and metastasis in cancers of the breast and ovary: invasion or proliferation?].
  Rochefort H. Rochefort H. C R Seances Soc Biol Fil. 1998;192(2):241-51. C R Seances Soc Biol Fil. 1998. PMID: 9841098 Review. French.
• IL-8 expression and its possible relationship with estrogen-receptor-negative status of breast cancer cells.
  Freund A, Chauveau C, Brouillet JP, Lucas A, Lacroix M, Licznar A, Vignon F, Lazennec G. Freund A, et al. Oncogene. 2003 Jan 16;22(2):256-65. doi: 10.1038/sj.onc.1206113. Oncogene. 2003. PMID: 12527894 Free PMC article.
• [Effect of interleukin-8 in cell invasion and proliferation of human breast cancer].
  Lin Y, Wang SM, Lü WM, Huang RP. Lin Y, et al. Zhonghua Wai Ke Za Zhi. 2005 Dec 1;43(23):1541-4. Zhonghua Wai Ke Za Zhi. 2005. PMID: 16412294 Chinese.
• Estrogens and their receptors in breast cancer progression: a dual role in cancer proliferation and invasion.
  Platet N, Cathiard AM, Gleizes M, Garcia M. Platet N, et al. Crit Rev Oncol Hematol. 2004 Jul;51(1):55-67. doi: 10.1016/j.critrevonc.2004.02.001. Crit Rev Oncol Hematol. 2004. PMID: 15207254 Review.

Cited by

• Effect of soluble factors derived from ZR 75.30 breast cancer cells on endothelial activation.
  Escalona-Guzman AR, Hernández-Garcia R, Vadillo-Ortega F, Lopez-Marure R, Mejia-Rangel J, Mitre-Aguilar IB, Cabrera-Quintero AJ, Zentella-Dehesa A. Escalona-Guzman AR, et al. Int J Clin Exp Pathol. 2018 Feb 1;11(2):685-694. eCollection 2018. Int J Clin Exp Pathol. 2018. PMID: 31938154 Free PMC article.
• Interleukin-8 in breast cancer progression.
  Todorović-Raković N, Milovanović J. Todorović-Raković N, et al. J Interferon Cytokine Res. 2013 Oct;33(10):563-70. doi: 10.1089/jir.2013.0023. Epub 2013 May 22. J Interferon Cytokine Res. 2013. PMID: 23697558 Free PMC article. Review.
• ERalpha-negative and triple negative breast cancer: molecular features and potential therapeutic approaches.
  Chen JQ, Russo J. Chen JQ, et al. Biochim Biophys Acta. 2009 Dec;1796(2):162-75. doi: 10.1016/j.bbcan.2009.06.003. Epub 2009 Jun 13. Biochim Biophys Acta. 2009. PMID: 19527773 Free PMC article. Review.
• Senescence-Associated Pro-inflammatory Cytokines and Tumor Cell Plasticity.
  Vernot JP. Vernot JP. Front Mol Biosci. 2020 May 13;7:63. doi: 10.3389/fmolb.2020.00063. eCollection 2020. Front Mol Biosci. 2020. PMID: 32478091 Free PMC article. Review.
• Epidermal growth factor and estrogen act by independent pathways to additively promote the release of the angiogenic chemokine CXCL8 by breast tumor cells.
  Haim K, Weitzenfeld P, Meshel T, Ben-Baruch A. Haim K, et al. Neoplasia. 2011 Mar;13(3):230-43. doi: 10.1593/neo.101340. Neoplasia. 2011. PMID: 21390186 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Ovid Technologies, Inc.
  • Wolters Kluwer

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information

• Research Materials

  • NCI CPTC Antibody Characterization Program

• Miscellaneous

  • NCI CPTAC Assay Portal